Cbl-c Ubiquitin Ligase Activity Is Increased via the Interaction of Its RING Finger Domain with a LIM Domain of the Paxillin Homolog, Hic 5

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Ryan, Philip E ^a,b   Kales, Stephen C ^a   Yadavalli, Rajgopal ^a   Nau, Marion M ^a   Zhang, Han ^a   Lipkowitz, Stanley ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HYDROGEN PEROXIDE INDUCED CONSTRUCT 5 PROTEIN; LIM PROTEIN; PAXILLIN; PROTEIN CBL C; PROTEIN TYROSINE KINASE; RING FINGER PROTEIN; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; ZINC;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MUTATION; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; UBIQUITINATION;

CELL LINE; HEK293 CELLS; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIM DOMAIN PROTEINS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTOR, EPIDERMAL GROWTH FACTOR; RING FINGER DOMAINS; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITINATION;

EID: 84868674485     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049428     Document Type: Article

References (49)

1. Fang S, Weissman AM, (2004) A field guide to ubiquitylation. Cell Mol Life Sci 61: 1546-1561.
2. Hershko A, Ciechanover A, (1998) The ubiquitin system. Annu Rev Biochem 67: 425-479.
3. Deshaies RJ, Joazeiro CA, (2009) RING domain E3 ubiquitin ligases. Annu Rev Biochem 78: 399-434.
4. Lipkowitz S, Weissman AM, (2011) RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat Rev Cancer 11: 629-643.
5. Lorick KL, Jensen JP, Fang S, Ong AM, Hatakeyama S, et al. (1999) RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci U S A 96: 11364-11369.
6. Ettenberg SA, Rubinstein YR, Banerjee P, Nau MM, Keane MM, et al. (1999) cbl-b inhibits EGF-receptor-induced apoptosis by enhancing ubiquitination and degradation of activated receptors. Mol Cell Biol Res Commun 2: 111-118.
7. Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, et al. (1999) Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol Cell 4: 1029-1040.
8. Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, et al. (2001) The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J Biol Chem 276: 14537-14540.
9. Okamoto K, Taya Y, Nakagama H, (2009) Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase. FEBS Lett 583: 2710-2714.
10. Tanimura S, Ohtsuka S, Mitsui K, Shirouzu K, Yoshimura A, et al. (1999) MDM2 interacts with MDMX through their RING finger domains. FEBS Lett 447: 5-9.
11. Kassenbrock CK, Anderson SM, (2004) Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations. J Biol Chem 279: 28017-28027.
12. Morris JR, Boutell C, Keppler M, Densham R, Weekes D, et al. (2009) The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature 462: 886-890.
13. Park HJ, Zheng H, Kulkarni D, Kerrigan J, Pungaliya P, et al. (2008) Identification of phosphorylation sites of TOPORS and a role for serine 98 in the regulation of ubiquitin but not SUMO E3 ligase activity. Biochemistry 47: 13887-13896.
14. Ryan PE, Sivadasan-Nair N, Nau MM, Nicholas S, Lipkowitz S, (2010) The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme. J Biol Chem 285: 23687-23698.
15. Doyle JM, Gao J, Wang J, Yang M, Potts PR, (2010) MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. Mol Cell 39: 963-974.
16. Nau MM, Lipkowitz S, (2003) Comparative genomic organization of the cbl genes. Gene 308: 103-113.
17. Nau MM, Lipkowitz S (2008) Welcome to the Family: Cbl-Famil Gene Organization, Overview of Structure and Functions of Cbl-Related Proteins in Various Taxonomical Groups. In: Tsygankov AY, editor. Cbl Proteins. 1 ed. New York: Nova Science Publishers, Inc. 3-25.
18. Griffiths EK, Sanchez O, Mill P, Krawczyk C, Hojilla CV, et al. (2003) Cbl-3-deficient mice exhibit normal epithelial development. Mol Cell Biol 23: 7708-7718.
19. Keane MM, Ettenberg SA, Nau MM, Banerjee P, Cuello M, et al. (1999) cbl-3: a new mammalian cbl family protein. Oncogene 18: 3365-3375.
20. Keane MM, Rivero-Lezcano OM, Mitchell JA, Robbins KC, Lipkowitz S, (1995) Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene. Oncogene 10: 2367-2377.
21. Langdon WY, Blake TJ, (1990) The human CBL oncogene. Curr Top Microbiol Immunol 166: 159-164.
22. Kim M, Tezuka T, Tanaka K, Yamamoto T, (2004) Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation. Oncogene 23: 1645-1655.
23. Tsui CC, Pierchala BA, (2008) CD2AP and Cbl-3/Cbl-c constitute a critical checkpoint in the regulation of ret signal transduction. J Neurosci 28: 8789-8800.
24. Bachmaier K, Krawczyk C, Kozieradzki I, Kong YY, Sasaki T, et al. (2000) Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403: 211-216.
25. Chiang YJ, Kole HK, Brown K, Naramura M, Fukuhara S, et al. (2000) Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403: 216-220.
26. Murphy MA, Schnall RG, Venter DJ, Barnett L, Bertoncello I, et al. (1998) Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol Cell Biol 18: 4872-4882.
27. Naramura M, Kole HK, Hu RJ, Gu H, (1998) Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc Natl Acad Sci U S A 95: 15547-15552.
28. Fujimoto N, Yeh S, Kang HY, Inui S, Chang HC, et al. (1999) Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. J Biol Chem 274: 8316-8321.
29. Shibanuma M, Mashimo J, Kuroki T, Nose K, (1994) Characterization of the TGF beta 1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence. J Biol Chem 269: 26767-26774.
30. Kadrmas JL, Beckerle MC, (2004) The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 5: 920-931.
31. Avraamides C, Bromberg ME, Gaughan JP, Thomas SM, Tsygankov AY, et al. (2007) Hic-5 promotes endothelial cell migration to lysophosphatidic acid. Am J Physiol Heart Circ Physiol 293: H193-203.
32. Mori K, Asakawa M, Hayashi M, Imura M, Ohki T, et al. (2006) Oligomerizing potential of a focal adhesion LIM protein Hic-5 organizing a nuclear-cytoplasmic shuttling complex. J Biol Chem 281: 22048-22061.
33. Fujita H, Kamiguchi K, Cho D, Shibanuma M, Morimoto C, et al. (1998) Interaction of Hic-5, A senescence-related protein, with focal adhesion kinase. J Biol Chem 273: 26516-26521.
34. Gao ZL, Deblis R, Glenn H, Schwartz LM, (2007) Differential roles of HIC-5 isoforms in the regulation of cell death and myotube formation during myogenesis. Exp Cell Res 313: 4000-4014.
35. Hagmann J, Grob M, Welman A, van Willigen G, Burger MM, (1998) Recruitment of the LIM protein hic-5 to focal contacts of human platelets. J Cell Sci 111 (Pt 15): 2181-2188.
36. Shibanuma M, Iwabuchi Y, Nose K, (2002) Possible involvement of hic-5, a focal adhesion protein, in the differentiation of C2C12 myoblasts. Cell Struct Funct 27: 21-27.
37. Shibanuma M, Mochizuki E, Maniwa R, Mashimo J, Nishiya N, et al. (1997) Induction of senescence-like phenotypes by forced expression of hic-5, which encodes a novel LIM motif protein, in immortalized human fibroblasts. Mol Cell Biol 17: 1224-1235.
38. Tumbarello DA, Turner CE, (2007) Hic-5 contributes to epithelial-mesenchymal transformation through a RhoA/ROCK-dependent pathway. J Cell Physiol 211: 736-747.
39. Ettenberg SA, Keane MM, Nau MM, Frankel M, Wang LM, et al. (1999) cbl-b inhibits epidermal growth factor receptor signaling. Oncogene 18: 1855-1866.
40. Kafatos FC, Christophides GK, (2006).
41. Yang XA, Dong XY, Li Y, Wang YD, Chen WF, (2004) Purification and refolding of a novel cancer/testis antigen BJ-HCC-2 expressed in the inclusion bodies of Escherichia coli. Protein Expr Purif 33: 332-338.
42. Matsuya M, Sasaki H, Aoto H, Mitaka T, Nagura K, et al. (1998) Cell adhesion kinase beta forms a complex with a new member, Hic-5, of proteins localized at focal adhesions. J Biol Chem 273: 1003-1014.
43. Shibanuma M, Kim-Kaneyama JR, Ishino K, Sakamoto N, Hishiki T, et al. (2003) Hic-5 communicates between focal adhesions and the nucleus through oxidant-sensitive nuclear export signal. Mol Biol Cell 14: 1158-1171.
44. Borden KL, Lally JM, Martin SR, O'Reilly NJ, Etkin LD, et al. (1995) Novel topology of a zinc-binding domain from a protein involved in regulating early Xenopus development. EMBO J 14: 5947-5956.
45. Matthews JM, Bhati M, Lehtomaki E, Mansfield RE, Cubeddu L, et al. (2009) It takes two to tango: the structure and function of LIM, RING, PHD and MYND domains. Curr Pharm Des 15: 3681-3696.
46. Ettenberg SA, Magnifico A, Cuello M, Nau MM, Rubinstein YR, et al. (2001) Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex. J Biol Chem 276: 27677-27684.
47. Lill NL, Douillard P, Awwad RA, Ota S, Lupher ML Jr, et al. (2000) The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor. J Biol Chem 275: 367-377.
48. Yokouchi M, Kondo T, Houghton A, Bartkiewicz M, Horne WC, et al. (1999) Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J Biol Chem 274: 31707-31712.
49. Dueber EC, Schoeffler AJ, Lingel A, Elliott JM, Fedorova AV, et al. (2011) Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination. Science 334: 376-380.